icon-folder.gif   Conference Reports for NATAP  
 
  EASL - The International Liver Congress 2014
49th Annual Meeting of the European
Association for the Study of the Liver
London, United Kingdom  April 9-13
Back grey_arrow_rt.gif
 
 
 
RESULTS FROM THE PHASE 2 PEARL-I STUDY: INTERFERON-FREE REGIMENS OF ABT-450/r + ABT-267 WITH OR WITHOUT RIBAVIRIN IN PATIENTS WITH HCV GENOTYPE 4 INFECTION
 
 
  Reported by Jules Levin
EASL - 11 April 2014 - 49th Annual Meeting of the European Association for the Study of the Liver, London, United Kingdom
 
Christophe Hezode, Patrick Marcellin, Stanislas Pol, Tarek Hassanein, Katarzyna Fleischer-Stepniewska, Tolga Baykal, Tianli Wang, Sandra S. Lovell, Tami Pilot-Matias, Regis A. Vilchez

EASL1.gif

EASL2.gif

EASL3.gif

EASL4.gif

EASL5.gif

EASL6.gif

EASL7.gif

EASL8.gif

EASL9.gif

EASL10.gif

EASL11.gif

EASL12.gif

EASL13.gif